JP Morgan Maintains Overweight on Comerica, Lowers Price Target to $97
JP Morgan analyst Steven Alexopoulos maintains Comerica (NYSE:CMA) with a Overweight and lowers the price target from $108 to $97.
JP Morgan Maintains Underweight on BankUnited, Lowers Price Target to $38
JP Morgan analyst Steven Alexopoulos maintains BankUnited (NYSE:BKU) with a Underweight and lowers the price target from $43 to $38.
Blueprint Medicines Received FDA Orphan Drug Designation for Treatment of Mastocytosis
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=890922
Wells Fargo Maintains Overweight on Kilroy Realty, Lowers Price Target to $60
Wells Fargo analyst Blaine Heck maintains Kilroy Realty (NYSE:KRC) with a Overweight and lowers the price target from $85 to $60.
Wells Fargo Maintains Equal-Weight on Hudson Pacific Properties, Lowers Price Target to $15
Wells Fargo analyst Blaine Heck maintains Hudson Pacific Properties (NYSE:HPP) with a Equal-Weight and lowers the price target from $30 to $15.
Wells Fargo Maintains Overweight on Highwoods Props, Lowers Price Target to $40
Wells Fargo analyst Blaine Heck maintains Highwoods Props (NYSE:HIW) with a Overweight and lowers the price target from $55 to $40.
Truist Securities Maintains Buy on Shake Shack, Lowers Price Target to $67
Truist Securities analyst Jake Bartlett maintains Shake Shack (NYSE:SHAK) with a Buy and lowers the price target from $86 to $67.
Wells Fargo Maintains Overweight on Douglas Emmett, Lowers Price Target to $28
Wells Fargo analyst Blaine Heck maintains Douglas Emmett (NYSE:DEI) with a Overweight and lowers the price target from $38 to $28.
Wells Fargo Maintains Overweight on Cousins Props, Lowers Price Target to $33
Wells Fargo analyst Blaine Heck maintains Cousins Props (NYSE:CUZ) with a Overweight and lowers the price target from $45 to $33.
JP Morgan Downgrades HBT Finl to Underweight, Lowers Price Target to $19
JP Morgan analyst Steven Alexopoulos downgrades HBT Finl (NASDAQ:HBT) from Neutral to Underweight and lowers the price target from $20 to $19.